Effect of AN-PEP Enzyme on Gluten Digestion
Launched by DSM FOOD SPECIALTIES · Apr 13, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
In this trial, the effect of AN-PEP enzyme on gastrointestinal breakdown of gluten will be investigated in healthy subjects. In addition, it will be assessed if meal calories can affect the efficacy of AN-PEP. Subjects receive intragastrically, either AN-PEP or placebo, with either a high or a low caloric meal in a double-blind, randomized, placebo-controlled, cross-over fashion. Gastrointestinal fluid will be sampled to measure breakdown of gluten.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male/female
- • Age ≥ 18 years but \< 45 years
- • Hormonal contraceptive treatment
- • Subject has read and understood the information provided on the study and given written informed consent
- Exclusion Criteria:
- • Any medical condition or laboratory test result that in the opinion of the investigators may interfere with the study and may jeopardise the health status of the participant
- • pregnancy or lactation
- • women not treated with hormonal contraceptive treatment
About Dsm Food Specialties
DSM Food Specialties is a leading global provider of innovative food ingredients and solutions, dedicated to enhancing the quality and sustainability of food products. As a division of DSM, a global science-based company, DSM Food Specialties leverages cutting-edge research and development to create high-performance ingredients that improve flavor, texture, and nutritional value while addressing the evolving needs of consumers and food manufacturers. With a commitment to sustainability and health, DSM Food Specialties actively engages in clinical trials to validate the efficacy and safety of its products, ensuring they meet the highest standards of quality and regulatory compliance in the food industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
Patients applied
Trial Officials
Ad Masclee, Prof Dr
Principal Investigator
Maastricht University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials